At Cellebration, we have mastered the technology for isolating the maximum number of viable stem cells from either the autologous sources of a patient’s own body or allogeneic from a matched donor to treat patients with Osteoarthritis.
Stem Cell treatment for Osteoarthritis involves administration of concentrated cells in the targeted area to form colonies, adapt the properties of resident stem cells, and initiate some of the lost functions that have been compromised by the disease or injury.
Stem cell treatments can address the challenges in disease progression as the most noninvasive treatment available to limit cell damage and reduce the symptoms. Stem cells are capable of differentiation into cell lines and can work in synchrony to treat patients with Osteoarthritis.
These cells are administered through one of two methods after an analysis of patient’s unique history.
Local Administration
In this mode, cells are infused directly at the targeted site of injury. In the case of osteoarthritis, stem cells are infused directly in the joints.
Intravenous Administration
In this delivery mode, cells are infused into the peripheral veins to expand blood volumes in the system, to ensure that the maximum number of cells are reaching the targeted area.
Once infused back into the body, these cells can be repopulated at the damaged parts of the joints. Through their strong paracrine effects, they differentiate into lost or damaged cells of the cartilage, bones, and muscles to improve the function of the muscular-skeletal system. With our standardized, broad based and holistic approach, it is now possible to obtain noticeable improvements in patients with Osteoarthritis, in the symptoms as well as their functional abilities.